| Literature DB >> 33552441 |
Anum Qureshi1, Emily Bergbower1, Janki Patel1.
Abstract
Acquired copper deficiency is rare but often seen among patients with intestinal malabsorption syndromes. Often times, these patients can develop myeloneuropathies with copper deficiency as an elusive culprit. With early diagnosis and appropriate supplementation, many symptoms, such as myeloneuropathy, can be reversed entirely. Checking copper levels should be included in the workup of myeloneuropathies to prevent irreversible damage and improving morbidity and mortality.Entities:
Keywords: Copper deficiency; malabsorption syndromes; myeloneuropathy
Year: 2021 PMID: 33552441 PMCID: PMC7850398 DOI: 10.1080/20009666.2020.1850989
Source DB: PubMed Journal: J Community Hosp Intern Med Perspect ISSN: 2000-9666
Figure 1.Copper absorption, distribution, and metabolism. Antonucci et al., 2017
Two cases of copper deficiency due to malabsorption leading to myeloneuropathy
| Case 1 | Case 2 | |
|---|---|---|
| Age | 45 | 69 |
| Sex | Male | Female |
| Medical History | Congenital atresia repaired in childhood and short gut syndrome | Stage IV colon cancer status post resection and colostomy |
| GI symptoms | Chronic Diarrhea | Constipation, nausea and vomiting |
| Neuro Symptoms | Bilateral hand and foot numbness, balance problem, multiple falls and wobble gait | Numbness and tingling of feet > hands |
| Exam | Sensory ataxia, loss of vibration and proprioception, hyporeflexia of the lower limb, broad-based ataxic gait, Romberg sign was positive as well. | Tremor of the outstretched tongue and hands, strength in her hands and legs 4/5, absent ankle and knee reflexes, decrease in sensation in a hands and feet in stocking distribution, reduced vibration and ataxia finger-to-nose testing. |
| X-ray Abdomen | – | Small bowel obstruction |
| CT/MRI | MRI: Subcortical, periventricular, and deep white matter T2/FLAIR abnormalities | CT scan of all spines: age related degenerative changes |
| Lumber Puncture | Not done | No acute abnormalities |
| Copper | 21 mcg/dL (71–175 mcg/dL) | 48 mcg/dL (71–175 mcg/dL) |
| Ceruloplasmin | 12 mg/dL (8–36 mg/dL) | – - |
| Treatment | 8 mg followed by 2 mg | 2 mg daily |
| Duration of Rx | 6 weeks | 2 weeks |
Differential diagnosis of myeloneuropathy
| Neoplastic/ Paraneoplastic | Lymphoma, Myeloma, leukemias |
| Metabolic | Diabetes, Amyloidosis, uremia, Vitamin/Mineral Deficiencies (B12, Folate, Vitamin E, Copper) |
| Infectious /Inflammatory | Sarcoidosis, GBS, Lyme, HIV, HTLV |
| Drugs/Toxins | Alcohol, Heavy metals, chemotherapeutic drugs |